Related Experiment Videos
Prostaglandin E1 vasospastic disease and thermography
Annals of the Rheumatic Diseases
|February 1, 1985
Summary
This study reveals quantitative thermographic differences in patients with Raynaud's syndrome (RS) compared to controls. Treatment with prostaglandin E1 (PGE1) improved thermographic responses, correlating with symptom relief in Raynaud's patients.
Area of Science:
- Medical Imaging
- Thermography
- Vascular Medicine
Background:
- Raynaud's syndrome (RS) is a condition causing exaggerated vasoconstriction in extremities.
- Objective thermographic assessment of RS and its response to treatment remains limited.
Purpose of the Study:
- To quantitatively assess thermographic differences between RS patients and healthy controls using cold stress testing.
- To evaluate the impact of prostaglandin E1 (PGE1) treatment on thermographic responses in RS patients.
- To correlate thermographic changes with clinical symptom improvement.
Main Methods:
- Quantitative thermography was employed before and after cold stress testing.
- Discriminant analysis was used to differentiate patients from controls based on temperature changes and thermal gradients.
- Patients received PGE1 treatment, and thermographic and symptomatic assessments were repeated.
Main Results:
- Significant quantitative thermographic differences were observed between RS patients and controls post-cold stress.
- PGE1 treatment led to improved thermographic responses in RS patients, normalizing discriminant values.
- Symptomatic improvement correlated strongly with enhanced thermographic measurements, persisting up to 12 weeks.
Conclusions:
- Quantitative thermography effectively distinguishes Raynaud's syndrome patients from controls.
- PGE1 treatment demonstrates a positive and sustained impact on thermographic parameters and symptoms in RS.
- Thermography serves as a valuable objective tool for assessing treatment efficacy in Raynaud's syndrome.